Table 2.
The neuropathic pain treatments
| Drug | Number of patients (n) | Percentage (%) |
|---|---|---|
| Monotherapy | 402 | 84.1 |
| Pregabalin | 283 | 59.2 |
| Gabapentin | 72 | 15.1 |
| Duloxetine | 35 | 7.3 |
| Carbamazepine | 4 | 0.8 |
| Amitriptyline | 2 | 0.4 |
| Fluoxetine | 2 | 0.4 |
| Escitalopram | 2 | 0.4 |
| Sertraline | 1 | 0.25 |
| Lamotrigine | 1 | 0.25 |
| Combination therapy | 76 | 15.9 |
| Pregabalin + Duloxetine | 48 | 10.0 |
| Gabapentin + Duloxetine | 5 | 1.0 |
| Pregabalin + Carbamazepine | 5 | 1.0 |
| Pregabalin + Amitriptyline | 4 | 0.8 |
| Pregabalin + Gabapentin | 4 | 0.8 |
| Carbamazepine + Amitriptyline | 2 | 0.4 |
| Pregabalin + Gabapentin + Duloxetine | 2 | 0.4 |
| Pregabalin + Amitriptyline + Duloxetine | 1 | 0.25 |
| Pregabalin + Amitriptyline + Carbamazepine | 1 | 0.25 |
| Pregabalin + Fluoxetine | 1 | 0.25 |
| Duloxetine + Fluoxetine | 1 | 0.25 |
| Gabapentin + Sertraline | 1 | 0.25 |
| Gabapentin + Amitriptyline | 1 | 0.25 |
| Total | 478 | 100.0 |